Page 20 - MI-2-4

Microbes & Immunity Regulation of Staphylococcus aureus CP biosynthesis

doi: 10.1128/iai.56.5.1090-1095.1988 43. Lehmann E, Van Dalen R, Gritsch L, et al. The capsular
polysaccharide obstructs wall teichoic acid functions in
33. Nanra JS, Buitrago SM, Crawford S, et al. Capsular
polysaccharides are an important immune evasion Staphylococcus aureus. J Infect Dis. 2024;230(5):1253-1261.
mechanism for Staphylococcus aureus. Hum Vaccin doi: 10.1093/infdis/jiae188
Immunother. 2013;9(3):480-487.
44. Kaku N, Ishige M, Yasutake G, et al. Long-term impact
doi: 10.4161/hv.23223 of molecular epidemiology shifts of methicillin-
resistant Staphylococcus aureus on severity and mortality
34. Thakker M, Park J, Carey V, Lee JC. Staphylococcus aureus
serotype 5 capsular polysaccharide is antiphagocytic and of bloodstream infection. Emerg Microbes Infect.
enhances bacterial virulence in a murine bacteremia model. 2025;14(1):2449085.
Infect Immun. 1998;11(66):5183-5189. doi: 10.1080/22221751.2024.2449085
doi: 10.1128/IAI.66.11.5183-5189.1998 45. Babra C, Tiwari J, Costantino P, et al. Human methicillin-
sensitive Staphylococcus aureus biofilms: Potential
35. Watts A, Ke D, Wang Q, et al. Staphylococcus aureus strains
that express serotype 5 or serotype 8 capsular polysaccharides associations with antibiotic resistance persistence and
differ in virulence. Infect Immun. 2005;73(6):3502-3511. surface polysaccharide antigens. J Basic Microbiol.
2014;54(7):721-728.
doi: 10.1128/IAI.73.6.3502-3511.2005
doi: 10.1002/jobm.201200557
36. Nilsson IM, Lee JC, Bremell T, Rydén C, Tarkowski A.
The role of staphylococcal polysaccharide microcapsule 46. Matthes R, Lührman A, Holtfreter S, et al. Antibacterial
expression in septicemia and septic arthritis. Infect Immun. activity of cold atmospheric pressure argon plasma against
1997;65(10):4216-4221. 78 genetically different (mecA, luk-P, agr or capsular
polysaccharide type) Staphylococcus aureus strains. Skin
doi: 10.1128/iai.65.10.4216-4221.1997 Pharmacol Physiol. 2016;29(2):83-91.
37. McLoughlin RM, Solinga RM, Rich J, et al. CD4+ T cells doi: 10.1159/000443210
and CXC chemokines modulate the pathogenesis of
Staphylococcus aureus wound infections. Proc Natl Acad Sci 47. Jansen A, Szekat C, Schröder W, et al. Production of capsular
USA. 2006;103(27):10408-10413. polysaccharide does not influence Staphylococcus aureus
vancomycin susceptibility. BMC Microbiol. 2013;13:65.
doi: 10.1073/pnas.0508961103
doi: 10.1186/1471-2180-13-65
38. Kuipers A, Stapels DAC, Weerwind LT, et al. The Staphylococcus
aureus polysaccharide capsule and Efb-dependent fibrinogen 48. Berni F, Enotarpi J, Voskuilen T, et al. Synthetic carbohydrate-
shield act in concert to protect against phagocytosis. based cell wall components from Staphylococcus aureus.
Microbiology (Reading). 2016;162(7):1185-1194. Drug Discov Today Technol. 2020;38:35-43.
doi: 10.1016/j.ddtec.2021.01.003
doi: 10.1099/mic.0.000293
49. Berti F, De Ricco R, Rappuoli R. Role of O-acetylation in
39. Sutra L, Rainard P, Poutrel B. Phagocytosis of mastitis
isolates of Staphylococcus aureus and expression of type 5 the immunogenicity of bacterial polysaccharide vaccines.
capsular polysaccharide are influenced by growth in the Molecules. 2018;23(6):1340.
presence of milk. J Clin Microbiol. 1990;28(10):2253-2258. doi: 10.3390/molecules23061340
doi: 10.1128/jcm.28.10.2253-2258.1990 50. Scully IL, Pavliak V, Timofeyeva Y, Liu Y, Singer C,
Anderson AS. O-Acetylation is essential for functional
40. Alvarez LP, Barbagelata MS, Gordiola M, Cheung AL,
Sordelli DO, Buzzola FR. Salicylic acid diminishes antibody generation against Staphylococcus aureus capsular
Staphylococcus aureus capsular polysaccharide type 5 polysaccharide. Hum Vaccin Immunother. 2018;14(1):81-84.
expression. Infect Immun. 2010;78(3):1339-1344. doi: 10.1080/21645515.2017.1386360
doi: 10.1128/IAI.00245-09 51. Fattom AI, Horwith G, Fuller S, Propst M, Naso R.
Development of StaphVAX, a polysaccharide conjugate
41. Brissac T, Martínez E, Kruckow KL, et al. Capsule promotes
intracellular survival and vascular endothelial cell vaccine against S. aureus infection: From the lab bench to
translocation during invasive pneumococcal disease. mBio. phase III clinical trials. Vaccine. 2004;22(7):880-887.
2021;12(5):e0251621. doi: 10.1016/j.vaccine.2003.11.034
doi: 10.1128/mBio.02516-21 52. Begier E, Seiden DJ, Patton M, et al. SA4Ag, a 4-antigen
Staphylococcus aureus vaccine, rapidly induces high levels of
42. Witte W. Transfer of drug-resistance-plasmids in mixed
cultures of Staphylococci. Zentralbl Bakteriol Orig A. bacteria-killing antibodies. Vaccine. 2017;35(8):1132-1139.
1977;237(2-3):147-159. doi: 10.1016/j.vaccine.2017.01.024

Volume 2 Issue 4 (2025) 12 doi: 10.36922/mi.8392